• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Philips Launches 3 New Fit for Purpose MR Smart Fit Coils

    Pulse Biosciences, CardioNXT Partner on First-in-Human Afib Study

    Agiliti Replaces CEO With Former Chief Executive

    Vindell Washington Joins Tactile Medical's Board of DIrectors

    First Patient Treated in Study of PercAssist's PSCA System
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    C-AXIS INC.

    Providence Enterprise USA Inc.

    Johari Digital Healthcare Ltd.

    Cirtec Medical

    Arthur G Russell Company, The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    C-AXIS INC.

    Providence Enterprise USA Inc.

    Johari Digital Healthcare Ltd.

    Cirtec Medical

    Arthur G Russell Company, The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Study: Apple Watch May Help Flag Heart Rhythm Problems

    The Apple Watch was able to detect AFib in a small group of people who had been alerted by the app as having an irregular heartbeat.

    Study: Apple Watch May Help Flag Heart Rhythm Problems
    American College of Cardiology03.18.19
    Amid the explosive popularity of the Apple Watch and other wearable fitness devices, along with new health care apps designed to track heart rate and other health measures, consumers have more opportunities than ever to monitor their own health data and make decisions about what to do with the information. The Apple Heart Study was designed to evaluate how well the Apple Watch can identify and prompt subsequent clinical evaluation for a common, yet often undiagnosed, heart rhythm disorder known as atrial fibrillation, or AFib, which is a leading cause of major stroke and hospitalizations. According to preliminary data from the study presented at the American College of Cardiology’s 68th Annual Scientific Session, the Apple Watch was able to detect AFib in a small group of people who had been alerted by the app as having an irregular heartbeat.
     
    AFib is estimated to affect up to 6 million Americans, yet many people don’t know they have it. AFib can lead to blood clots, disabling stroke, heart failure, and other heart-related complications.
     
    For this study, researchers at Stanford University School of Medicine specifically evaluated a mobile app that uses the watch’s existing light sensor technology (called photoplethysmography) to intermittently measure blood flow activity and detect subtle changes that might indicate an irregular contraction or heartbeat. The Apple Watch generates a tachogram, which is a plot of time between heartbeats. If an irregular tachogram is seen, then more frequent tachogram collection occurs. The tachograms are analyzed by an algorithm to determine if an irregular rhythm may be present and, if so, a notification is sent to the watch.
     
    The main study goals were to determine: the proportion of participants with an irregular pulse watch notification who have AFib on a subsequent electrocardiogram (ECG) patch worn at home, how well the algorithm on the watch matched the ECG findings and the percentage of patients who received a notification who went on to seek medical help through the app. Of the 419,297 people who self-enrolled in this prospective study between November 2017 and July 2018, 0.5 percent (nearly 2,100 participants) received an irregular pulse notification, which was triggered if the sensor detected 5 out of 6 repeat episodes (or tachograms) of an irregular pulse within a 48-hour period.
     
    “The app continuously gathers data in the background without the wearer of the device doing anything, so it’s very opportunistic in this way,” said Mintu Turakhia, M.D., associate professor of cardiovascular medicine, Stanford School of Medicine, and the study’s co-principal investigator, adding that the entire user experience, end-to-end was directly through the study application. “[Overall], this study improves our understanding of how this wearable technology and app works in the real-world setting and how well the technology can detect long periods of AFib. Notifications of heart rhythm irregularities were low, an important finding given concerns about over notification, and we were able to see what happened downstream after participants received a notification.”
     
    Participants who got a notification were also prompted to contact the study doctor through the app. Based on a video consultation on their device, it was decided whether the person should wear an electrocardiogram (ECG) patch, sent by mail, to measure their heart’s activity and potentially identify AFib. Participants wore it for up to seven days and then sent it back to determine whether AFib was evident. In total, 658 participants were sent a patch and 450 were returned and included in the analyses. One-third (34 percent) of the participants who had received an irregular pulse notification on their Watch and wore the ECG patch over a week later were then found to have AFib based on the ECG reading, which researchers said is not entirely unexpected.
     
    “AFib can come and go, particularly early on in the course of the disease. It’s not surprising for it to go undetected in subsequent ECG patch monitoring. So while only 34 percent of people who were still having [signs of] AFib on the ambulatory ECG, that doesn’t mean that 66 percent didn’t have AFib. It just means that AFib may not have been there at the time,” Turakhia said. “These parameters help us understand how we, as clinicians, should think about these notifications.”
     
    When comparing pulse detections on the watch with simultaneous ECG patch recordings among 450 participants who wore both at the same time, researchers found that the positive predictive value for the tachogram was 71 percent, and the positive predictive value for the notification was 84 percent. This means if a notification occurred, 84 percent of the time, the ambulatory ECG monitor also showed AFib.
     
    Of the participants who received an irregular pulse notification via the app to confer with a study doctor to determine next steps, about half ended up initiating contact with the study doctor, but researchers said the others may have sought care elsewhere. In subsequent surveys, 57 percent of people who got an alert said they sought medical attention outside of the study regardless of whether they had been seen virtually by a study doctor.
     
    Participants were required to have an Apple Watch (series 1, 2 or 3) and a compatible iPhone (iPhone 5S or later), be age ≥ 22 and a U.S. resident. The newer Apple Watches that feature a built-in ECG app were not part of this study. Participants downloaded the application to their device and were subsequently given information about the study, questions to help verify their eligibility and prompts to provide signed consent. They were not included in the study if they said they were taking an anticoagulant for any reason or had current or prior AFib. Surveys were used to collect information about patient-reported outcomes.
     
    Notification rates in people under 40 years of age were very low (0.16 percent) and were more frequent in those over age 65 (just over 3 percent).
     
    “This is encouraging because it tracks with our understanding of AFib as being more common as you get older,” Turakhia said, adding that the overall study population represented a striking cross-section of cardiovascular risk.
     
    Five percent had diabetes, 21 percent had high blood pressure, 1 percent had a prior stroke and 38 percent were obese based on body mass index.
     
    About one-third of people who received a notification had a CHADS-VASc score of two or greater, which is used to predict the risk of stroke in people with AFib and is the threshold to start anti-coagulation. People with AFib have more than five times the risk of having a stroke than someone without it.
     
    There were several study limitations, including researchers’ reliance on self-reported data from participants. Researchers said they also did not reach their target enrollment of 500,000 participants, of which they hoped 75,000 would be age 65 and older. But they explained this virtual study is step one in creating the groundwork for future studies that look to leverage wearable technologies as a way to support heart health outside of the clinic. They said an obvious next step is to study how this technology can be used in complement with other technologies such as real-time ECG and other validated tools to manage heart rhythm problems.
     
    “It really represents a paradigm shift for how clinical studies can be conducted,” Turakhia said. “We don’t have to bring people into a brick and mortar clinic and give the study intervention.”
     
    The study was funded by Apple Inc.
    Related Searches
    • blood pressure
    • apps
    • atrial fibrillation
    • apple
    Related Knowledge Center
    • Patient Monitoring
    • Cardiovascular
    Suggested For You
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Glooko’s Remote Patient Monitoring for Diabetics Glooko’s Remote Patient Monitoring for Diabetics
    Why Patient Data Security is of Essential Importance in 2021 Why Patient Data Security is of Essential Importance in 2021
    Valencell’s Wearable Biomedical Sensors Valencell’s Wearable Biomedical Sensors
    The Importance of Metal Fabrication in the Innovation of Medical Devices The Importance of Metal Fabrication in the Innovation of Medical Devices
    HD Medical Appoints Shaun Setty as Chief Medical Officer HD Medical Appoints Shaun Setty as Chief Medical Officer
    Regulating IVDs and LDTs—Mike on Medtech Regulating IVDs and LDTs—Mike on Medtech
    Greg Cebular Named as President of Mack Prototype Greg Cebular Named as President of Mack Prototype
    Facility Falsified Sterilization Data—Mike on Medtech Facility Falsified Sterilization Data—Mike on Medtech
    Knobbe Martens Talks Trade Secrets Knobbe Martens Talks Trade Secrets
    Canary Medical’s ‘Smart’ Implants Canary Medical’s ‘Smart’ Implants
    Implicity’s Cardiac Device Remote Monitoring Implicity’s Cardiac Device Remote Monitoring
    PixCell PixCell's Rapid Blood Test Diagnostics
    Top 483s of 2020—Mike on Medtech Top 483s of 2020—Mike on Medtech

    Related Breaking News

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21

    • Surgical
      Molli Surgical

      Molli Surgical's Breast Tumor Marker

      MPO's Sean Fenske speaks with Dr. Fazila Seker of MOLLI Surgical about the benefits of her company’s breast tumor marking system.
      Sean Fenske, Editor-in-Chief 09.14.21

    • Chronic Disease
      Glooko’s Remote Patient Monitoring for Diabetics

      Glooko’s Remote Patient Monitoring for Diabetics

      MPO's Sean Fenske speaks with Russ Johannesson of Glooko about the advantages of being able to monitor diabetes remotely.
      Sean Fenske, Editor-in-Chief 08.31.21


    • Digital Health
      Why Patient Data Security is of Essential Importance in 2021

      Why Patient Data Security is of Essential Importance in 2021

      How to protect confidential patient information and comply with regulations such as HIPAA.
      Anton Zheliabin, Product manager, ComeBack Mobility 08.25.21

    • Patient Monitoring
      Valencell’s Wearable Biomedical Sensors

      Valencell’s Wearable Biomedical Sensors

      MPO's Sean Fenske speaks with Dr. Steven LeBoeuf of Valencell about the advantage of biomedical sensors that can be integrated into many devices.
      Sean Fenske, Editor-in-Chief 08.24.21

    Loading, Please Wait..

    Breaking News
    • Philips Launches 3 New Fit for Purpose MR Smart Fit Coils
    • Pulse Biosciences, CardioNXT Partner on First-in-Human Afib Study
    • Agiliti Replaces CEO With Former Chief Executive
    • Vindell Washington Joins Tactile Medical's Board of DIrectors
    • First Patient Treated in Study of PercAssist's PSCA System
    View Breaking News >
    CURRENT ISSUE

    November 2023

    • MPO's 2023 Medical Device Industry Year in Review
    • The Beat Goes On in the Cardiovascular Device Market
    • Medical Manufacturers Gain Support from 3D Printing
    • The Intelligent Tools Medical Device Manufacturers Already Own
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Tocotrienol Supplementation May Aid Liver Function in Diabetes, MASL Patients
    Euromed Receives EcoVadis Platinum Medal for ESG Efforts
    Rousselot Receives U.S. Patent for Gelatin that Improves Softgel Stability, Efficacy
    Coatings World

    Latest Breaking News From Coatings World

    BASF: Chemistry and Sustainability – A Perfect Match
    PPG Again Recognized Among Foundry’s Computerworld ‘Best Places to Work in IT in 2024’
    Dunn-Edwards Celebrates Opening of Santa Rosa, CA Storefront
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Philips Launches 3 New Fit for Purpose MR Smart Fit Coils
    Pulse Biosciences, CardioNXT Partner on First-in-Human Afib Study
    Agiliti Replaces CEO With Former Chief Executive
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Fujifilm Invests $200M to Expand Cell Therapy Capabilities
    Applied StemCell Expands Leadership Team
    Oxford Acquires ABL Europe from Institut Mérieux for €15M
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Varsity Spirit Introduces Beauty Line Inspired by and Designed for Athletes
    Amyris Sells Four Consumer Beauty Brands
    Anisa International Earns Silver Sustainability Rating from EcoVadis
    Happi

    Latest Breaking News From Happi

    Hempz Debuts Limited Edition Holiday Collection
    Designs for Health Launches Two New Collagen Formulas
    Doug Gillespie Appointed CEO of Beauty By Imagination, Inc.
    Ink World

    Latest Breaking News From Ink World

    Chemistry and Sustainability – A Perfect Match: BASF
    Xeikon Highlights Digital Expertise at Labelexpo Asia
    Kongsberg Launches New Digital Cutting Platform
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Lecta unveils new functional Metalvac papers
    Bunting announces leadership changes
    Avery Dennison achieves +Vantage Vinyl verification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Bunting Magnetics Announces Personnel Appointments
    Mativ Completes Sale of Engineered Papers Business
    Mehmet Dasdemir Joins Nonwovens Institute
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Nalu SCS System Shows 75% Pain Reduction in U.S. Study
    CTL Amedica’s MONET ACIF Approved for Use in Mexico
    New Wearable Device Helps Improve Postural Control and Reduce Fall Risk
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    NRF Announces FedEx CEO Raj Subramaniam as Keynote Speaker
    ams OSRAM Launches SFH 7018 Multi-LED Package
    Applied Materials Receives SBTi Validation

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login